CN Patent

CN113387923A — 硫辛酸胆碱酯盐的药物组合物及使用其的治疗方法

Assigned to Novartis AG · Expires 2021-09-14 · 5y expired

What this patent protects

本披露提供了硫辛酸胆碱酯(LACE)的盐、其结晶形式，以及其使用方法。本披露进一步提供了LACE盐的药物组合物及其使用方法。

USPTO Abstract

本披露提供了硫辛酸胆碱酯(LACE)的盐、其结晶形式，以及其使用方法。本披露进一步提供了LACE盐的药物组合物及其使用方法。

Drugs covered by this patent

Arnuity Ellipta (FLUTICASONE FUROATE) · Haleon Us Holdings

Patent Metadata

Patent number: CN113387923A
Jurisdiction: CN
Classification: —
Expires: 2021-09-14
Drug substance claim: No
Drug product claim: No
Assignee: Novartis AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.